Healthcare professionals may consider genetic testing when a person has a family history of an inherited condition, unexplained medical findings, certain types of cancer, or a potential inherited risk. Genetic testing can also be used in reproductive planning and newborn screening.

Common categories include:

• Diagnostic testing: Helps investigate whether a genetic condition may explain existing symptoms or clinical findings.

• Carrier screening: Identifies whether someone carries certain genetic variants that could potentially be passed to children.

• Predictive or risk testing: Looks for variants associated with an increased likelihood of developing particular conditions.

• Prenatal testing: Examines fetal genetic or chromosomal information during pregnancy.

• Newborn screening: Tests newborns for selected conditions where early identification can be important.

• Pharmacogenetic testing: Examines genetic differences that may influence how someone responds to certain medicines.

Genetic testing is different from a routine medical laboratory test because DNA findings can have implications for relatives as well as the person being tested.

Why Genetic Testing Matters

Genetic information can provide another layer of evidence when doctors evaluate a person's health history, symptoms, or potential inherited risks.

A genetic result may be particularly useful when combined with:

• Personal and family medical history

• Physical examination findings

• Imaging or laboratory results

• Age and other relevant clinical factors

• Information about relatives with similar conditions

A positive genetic result does not always mean that a person will develop a disease. Likewise, a negative result does not necessarily eliminate every possible genetic or non-genetic risk.

Some tests produce a variant of uncertain significance (VUS). This means the available evidence is not sufficient to determine whether the genetic change is associated with a health condition. A VUS generally should not be treated as equivalent to a confirmed disease-causing variant.

Genetic counseling can help people understand what a test can and cannot determine before testing takes place.

Types of DNA Screening and Genetic Tests

Different testing methods answer different questions.

Single-gene testing

This approach focuses on one gene when a particular inherited condition is strongly suspected.

Gene-panel testing

A panel evaluates several genes associated with a particular condition or group of conditions. It can be useful when multiple genes could produce similar clinical findings.

Whole-exome sequencing

Whole-exome sequencing examines the protein-coding portions of many genes. It may be considered when a genetic cause is suspected but a specific gene has not been identified.

Whole-genome sequencing

Whole-genome sequencing examines a much larger portion of DNA than targeted testing and can identify certain types of genetic variation that may not be captured through narrower tests.

Chromosomal testing

Chromosome analysis can identify certain changes involving chromosome number or structure.

Pharmacogenomic testing

Pharmacogenomic testing examines genetic variants that may influence how the body processes or responds to selected medications. Results may sometimes contribute to medication-selection decisions, but they do not replace clinical judgment.

How Genetic Testing Works

The testing process usually begins with a medical or genetic assessment.

A typical process may include:

1. Health-history review — Personal and family history can help determine whether testing is appropriate.

2. Test selection — The type of test depends on the medical question.

3. Sample collection — Depending on the test, a sample may involve blood, saliva, cheek cells, or another biological specimen.

4. Laboratory analysis — DNA is analyzed for specific genetic variations.

5. Result interpretation — Results are evaluated using established laboratory and clinical information.

6. Follow-up discussion — A healthcare professional or genetic counselor may explain what the findings mean.

The interpretation stage is particularly important because genetic results can be complex.

Understanding Genetic Test Results

Genetic reports commonly classify findings according to the evidence available about a particular variant.

Possible classifications include:

• Pathogenic: Evidence supports an association with disease.

• Likely pathogenic: Available evidence indicates that the variant is probably disease-associated.

• Uncertain significance: Evidence is currently insufficient to determine the clinical significance.

• Likely benign: Available evidence suggests the variant is probably not associated with disease.

• Benign: Evidence supports that the variant is not disease-causing.

A result should always be interpreted in context. The same genetic finding can have different implications depending on the condition, family history, laboratory methodology, and current scientific evidence.

Genetic knowledge also changes over time. A previously uncertain result may be reclassified as more evidence becomes available.

Genetic Testing and Family Health

One important feature of genetic information is that it can sometimes have implications for biological relatives.

If a clinically significant inherited variant is identified, healthcare professionals may discuss whether relatives could benefit from additional evaluation or testing.

This can help families understand patterns of inherited conditions and support appropriate medical monitoring.

However, genetic information can also raise emotional, ethical, privacy, and family-communication considerations. Genetic counseling can help individuals understand these issues before making decisions about testing.

Genetic Testing in Cancer Risk Assessment

Genetic testing is also used in some cancer-risk assessments.

Certain inherited variants can increase susceptibility to particular cancers. Testing may be considered when personal or family history suggests a possible hereditary cancer syndrome.

The presence of an inherited risk variant does not mean that cancer is certain to develop. Instead, the finding may influence discussions about screening, risk management, and family testing.

Cancer-related genetic testing is most useful when the test is selected and interpreted in an appropriate clinical context.

Recent Developments in Genetic Testing

Genomic medicine continues to develop as sequencing technologies, laboratory methods, and interpretation databases improve.

Important developments include:

• Greater use of multi-gene panels for conditions involving several possible genes

• Increased use of exome and genome sequencing for difficult-to-diagnose cases

• Improvements in interpretation of rare genetic variants

• Expansion of pharmacogenomic research

• More attention to genetic data privacy and informed consent

• Continued development of newborn and reproductive genetic screening

• Greater use of clinical databases to support variant interpretation

Artificial intelligence and computational tools are also increasingly being studied for genomic data analysis. These technologies can help researchers identify patterns in large datasets, but clinical interpretation still requires appropriate validation and professional oversight.

Laws, Policies, and Privacy Considerations

Genetic information can be sensitive because it may reveal information about inherited health risks and biological relationships.

In the United States, the Genetic Information Nondiscrimination Act (GINA) provides certain federal protections against genetic-information discrimination in health insurance and employment. However, GINA does not cover every type of insurance or every situation.

The Health Insurance Portability and Accountability Act (HIPAA) can also apply to protected health information held by covered healthcare organizations and certain related entities.

Privacy practices can vary depending on where testing is performed and how genetic data is handled. Before testing, it is useful to understand:

• Who can access the genetic information

• How long the data may be retained

• Whether data may be used for research

• Whether information may be shared with third parties

• Whether biological samples are retained

• What options exist for withdrawing consent

Direct-to-consumer genetic testing can have different privacy terms from clinical genetic testing, so users should carefully review the applicable privacy documentation.

Tools and Resources

Several established organizations provide educational information about genetics and genomic medicine.

Useful resources include:

• National Human Genome Research Institute (NHGRI): General information about genetics and genomics.

• MedlinePlus Genetics: Educational information about genes, genetic conditions, and inheritance.

• Centers for Disease Control and Prevention (CDC): Information about genomics and public-health applications.

• National Cancer Institute (NCI): Information about hereditary cancer risk and genetic testing.

• Genetic counseling resources: Can help individuals understand whether genetic testing may be appropriate and how results could affect medical decisions.

For medical decision-making, laboratory reports should be discussed with an appropriately qualified healthcare professional rather than interpreted solely from an online database.

FAQs

What does genetic testing look for?
Genetic testing looks for changes or variants in DNA. Depending on the test, it may focus on one gene, multiple genes, chromosomes, or broader genomic regions.

Does a positive genetic test mean someone will develop a disease?
Not necessarily. The meaning of a positive result depends on the specific variant, condition, inheritance pattern, and available scientific evidence.

What does a negative genetic test mean?
A negative result means the test did not identify the genetic changes it was designed to detect. It does not necessarily rule out every genetic or environmental cause of a condition.

Can genetic testing identify health risks?
Some tests can identify genetic variants associated with increased susceptibility to particular conditions. Risk interpretation should consider family history and other clinical factors.

Should genetic testing results be discussed with a doctor?
Yes. Genetic results can be complex, and a qualified healthcare professional or genetic counselor can explain their significance and limitations.

Conclusion

Genetic testing has become an important part of modern genomic medicine, with applications ranging from inherited-condition evaluation and reproductive planning to cancer-risk assessment and pharmacogenomics.

The most useful interpretation comes from combining DNA findings with medical history, family history, clinical information, and current scientific evidence. Because genetic knowledge continues to evolve, some findings may also be reassessed as new evidence becomes available.

Understanding the purpose of a test, the type of information it can provide, its limitations, and the privacy considerations involved can help people make more informed decisions about genetic health information.